Enblo (enavogliflozin) / Daewoong Pharma, GC Biopharma, M8 Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Enblo (enavogliflozin) / Daewoong Pharma, GC Biopharma, M8 Pharma
NCT04014023: Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

Unknown status
2
196
RoW
DWP16001, Placebo
Daewoong Pharmaceutical Co. LTD.
T2DM (Type 2 Diabetes Mellitus)
03/20
06/20

Download Options